Selskabets formål er handel med og produktion af medicin og farmaceutiske behandlingsmidler og produkter til brug indenfor medicinalindustrien samt anden dermed i forbindelse stående virksomhed
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 19.9 mio. | 6 mio. | 70.9 mio. | 43.2 mio. | 15 | |
CVR: 72246012
Compared to 288 companies in Engroshandel med læge- og hospitalsartikler
Comparison is based on industry median values
Companies in the same industry and area
CVR 29603537
CVR 26400260
CVR 40504044
CVR 37940844
CVR 31412390
BAXTER A/S demonstrates a stable financial position with a solid equity base of 43,188,851 DKK in 2024, although it has experienced a notable decline in revenue from 53,718,413 DKK in 2023 to 19,918,485 DKK in 2024. Profitability remains strong, with a profit of 6,024,562 DKK in 2024, indicating healthy margins despite the revenue drop. The company has shown consistent profit levels over the past few years, but the significant decrease in revenue raises concerns about its market position and operational challenges. Overall, BAXTER A/S maintains a robust equity position, which could provide a buffer against potential downturns in the competitive medical supplies industry.
AI-generated summary
companydata.dk